Endocrine News

2 days ago | endocrinenews.endocrine.org | Mark Newman

The Endocrine Society has selected Yoshitomo Hoshino, MD, PhD, as the recipient of its 2025 C. Wayne Bardin, MD, International Travel Award for his outstanding ENDO abstract and research contributions to the care of patients with bone health disorders. The C. Wayne Bardin, MD, International Travel Award was created in honor of Past President Wayne Bardin, who made remarkable research contributions to both reproductive physiology and contraception throughout his long career.

1 week ago | endocrinenews.endocrine.org | Glenda Fauntleroy Shaw |Derek Bagley

Barbara Kahn, MD, initially pursued medical school to understand how the human body works and to help patients with chronic illnesses. During her general medicine fellowship, her cross-over study on blood glucose and urine glucose monitoring led to invitations from U.K. researchers to tour their research institutes — a pivotal experience that revealed basic research as an alternate path to her goal of helping people with chronic illnesses live long, gratifying lives.

1 week ago | endocrinenews.endocrine.org | Derek Bagley

Last month Corcept Therapuetics Incoporated announced that the U.S. Food and Drug Administration (FDA) filed its New Drug Application (NDA) submission for the company’s proprietary, selective cortisol modulator, relacorilant, to treat patients with endogenous hypercortisolism (Cushing’s syndrome). Corcept’s NDA is based on positive results from the pivotal GRACE trial and confirmatory evidence from the Phase 3 GRADIENT trial, long-term extension trial, and a Phase 2 trial in hypercortisolism.

2 weeks ago | endocrinenews.endocrine.org | Kelly Horvath |Derek Bagley |Mark Newman

With evidence proliferating that endocrine-disrupting chemicals (EDCs) affect thyroid hormone synthesis, transport, metabolism, and action; that gestational exposure to environmental thyroid hormone disruptors affects cognitive function; and that exposure in general increases thyroid cancer risk, one session at ENDO 2025 explores these deleterious effects and some of their proposed underlying mechanisms in detail.

3 weeks ago | endocrinenews.endocrine.org | Derek Bagley

At a GlanceEndocrine-disrupting chemicals have for years been implicated in endocrine diseases like cancer, reproductive issues, and obesity. Now they’ve been shown to contribute to psychological problems. A recent animal study showed that early-life exposure to polychlorinated biphenyls may be linked to behavioral and psychological problems later in life.